Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Placebo-Controlled Adaptive Study of Intravenous COL-144 in Acute Migraine
2006-003903-38Phase 2Completed
- Sponsor
- CoLucid Pharmaceuticals
- Start
- Aug 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in migraine comparing Intravenous COL-144 with Placebo (2 arms). Primary endpoint: Headache response at 2 hours. Started Aug 2006; status: completed.
02
Drugs
lasmiditan
03
Conditions
migraine
Beyond the preview
Go deeper on 2006-003903-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-003903-38.